Chronic CNS administration of Agouti-related protein (Agrp) reduces energy expenditure

International Journal of Obesity

Volumn 27, Issue 4, 2003, Pages 530-533

  Small, C J ^a   Liu, Y L ^b   Stanley, S A ^a   Connoley, I P ^b   Kennedy, A ^a   Stock, M J ^b   Bloom, S R ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Brown adipose tissue (BAT); Hypothalamus; MC4 receptor; Melanocortin; Oxygen consumption; Uncoupling protein 1 (UCP 1)

Indexed keywords

4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID METHYL ESTER; ADRENERGIC RECEPTOR STIMULATING AGENT; AGOUTI RELATED PROTEIN; MELANOCORTIN RECEPTOR; UNCOUPLING PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CENTRAL NERVOUS SYSTEM; COLON; CONTROLLED STUDY; CORE TEMPERATURE; DRUG MECHANISM; ENERGY EXPENDITURE; FOOD INTAKE; HYPOTHALAMUS; NONHUMAN; OBESITY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; RESPIROMETER; THERMOGENESIS;

ADIPOSE TISSUE, BROWN; ANIMALS; CENTRAL NERVOUS SYSTEM; EATING; ENERGY METABOLISM; INJECTIONS, INTRAVENTRICULAR; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OXYGEN CONSUMPTION; PROTEINS; RATS; RATS, WISTAR; WEIGHT GAIN;

AGOUTI; ANIMALIA;

EID: 0041944526     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802253     Document Type: Article

References (21)

1. Barsh G. From Agouti to Pomc - 100 years of fat blonde mice. Nat Med 1999; 5: 984-985.
2. Rossi M, Kim MS, Morgan DG, Small CJ, Edwards CM, Sunter D, Abusnana S, Goldstone AP, Russell SH, Stanley SA, Smith DM, Yagaloff K, Ghatei MA, Bloom SR. A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology 1998; 139: 4428-4431.
3. Kask A, Rago L, Wikberg JE, Schioth HB. Evidence for involvement of the melanocortin MC4 receptor in the effects of leptin on food intake and body weight. Eur J Pharmacol 1998; 360: 15-19.
4. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997; 385: 165-168.
5. Skuladottir GV, Jonsson L, Skarphedinsson JO, Mutulis F, Muceniece R, Raine A, Mutule I, Helgason J, Prusis P, Wikberg JE, Schioth HB. Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist. Br J Pharmacol 1999; 126: 27-34.
6. Raposinho PD, Castillo E, D'Alleves V, Broqua P, Pralong FP, Aulbert ML. Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axes. Endocrinology 2000; 141: 4419-4427.
7. Satoh N, Ogawa Y, Katsuura G, Numata Y, Masuzaki H, Yoshimasa Y, Nakao K. Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system. Neurosci Lett 1998; 249: 107-110.
8. Hwa JJ, Ghibaudi L, Gao J, Parker EM. Central melanocortin system modulates energy intake and expenditure of obese and lean Zucker rats. Am J Physiol Regul Integr Comp Physiol 2001; 281: R444-R451.
9. Jonsson L, Skarphedinsson JO, Skuladottir GV, Atlason PT, Eiriksdottir VH, Franzson L, Schioth HB. Melanocortin receptor agonist transiently increases oxygen consumption in rats. Neuroreport 2001; 12: 3703-3708.
10. Fekete C, Legradi G, Mihaly E, Tatro JB, Rand WM, Lechan RM. alpha-Melanocyte stimulating hormone prevents fasting-induced suppression of corticotropin-releasing hormone gene expression in the rat hypothalamic paraventricular nucleus. Neurosci Lett 2000; 289: 152-156.
11. Kim MS, Small CJ, Stanley SA, Morgan DG, Seal LJ, Kong WM, Edwards CM, Abusnana S, Sunter D, Ghatei MA, Bloom SR. The central melanocortin system affects the hypothalamo-pituitary-thyroid axis and may mediate the effect of leptin. J Clin Invest 2001; 105: 1005-1011.
12. Small CJ, Kim MS, Stanley SA, Mitchell JR, Murphy K, Morgan DG, Ghatei MA, Bloom SR. Effects of chronic central nervous system administration of agoutl-related protein in pair-fed animals. Diabetes 2001; 50: 248-254.
13. Meeran K, O'Shea D, Edwards CM, Turton MD, Heath MM, Gunn I, Abusnana S, Rossi M, Small CJ, Goldstone AP, Taylor GM, Sunter D, Steere J, Choi SJ, Ghatei MA, Bloom SR. Repeated intracerebroventricular administration of glucagon-like peptide-1 -(7-36) amide or exendin -(9-39) alters body weight in the rat. Endocrinology 1999; 140: 244-250.
14. Connoley IP, Liu YL, Frost I, Reckless IP, Heal DJ, Stock MJ. Thermogenic effects of sibutramine and its metabolites. Br J Pharmacol 1999; 126: 1487-1495.
15. Liu YL, Stock MJ. Acute administration of the beta3-adrenoceptor agonist, BRL 35135, on tissue glucose utilisation. Br J Pharmacol. 1995; 114: 888-894.
16. Stock MJ. An automatic, closed-circuit oxygen consumption apparatus for small animals. J Appl Physiol 1975; 39: 849-850.
17. Wang T, Hartzell DL, Rose BS, Flatt WP, Hulsey MG, Menon NK, Makula RA, Baile CA. Metabolic responses to intracerebroventricular leptin and restricted feeding. Physiol Behav. 1999; 65: 839-848.
18. Overton JM, Williams TD, Chambers JB, Rashotte ME. Chronic leptin infusion attenuates the cardiovascular and metabolic effects of fasting in rats. Hypertension 2001; 37: 663-669.
19. Griggio MA, Luz J, Carvalho SM. The effect of fasting and refeeding on oxygen consumption by rats. Braz J Med Biol Res 1992; 25: 205-208.
20. Bing C, Hopkins D, Wang Q, Frankish H, Buckingham R, Williams G. Direct stimulation of BAT thermogenesis does not affect hypothalamic neuropeptide Y. Peptides 1998; 19: 167-170.
21. Murgatroyd PR, Shetty PS, Prentice AM. Techniques for measurement of human energy expenditure: a practical guide. Int J Obes Relat Metab Disord 1993 Oct; 17(10): 549-568.